Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience
SL Alnuaimy, RP Shamoon - Blood Coagulation & Fibrinolysis, 2023 - journals.lww.com
Objectives We aimed to detect the incidence of disseminated intravascular coagulation
(DIC) in patients with acute leukemia (AL) and find out its association with types of AL and …
(DIC) in patients with acute leukemia (AL) and find out its association with types of AL and …
Acute promyelocytic leukaemia: A central South African experience
W Naicker, J Kloppers, FC van Rooyen… - SA Journal of …, 2023 - journals.co.za
Background Targeted therapies combined with anthracycline chemotherapy have improved
the survival of patients with acute promyelocytic leukaemia (APL). High short-term mortality …
the survival of patients with acute promyelocytic leukaemia (APL). High short-term mortality …
Acute myeloid leukaemia in the Johannesburg public sector: A laboratory-based study
J Vaughan, K Hodkinson - SA Journal of Oncology, 2024 - journals.co.za
Background Acute myeloid leukaemia (AML) is a haematological malignancy stratified into
low, intermediate and high-risk groups according to the genetic abnormalities present at …
low, intermediate and high-risk groups according to the genetic abnormalities present at …
Incidence of QT interval prolongation during arsenic trioxide-based therapy in a sample of Iraqi adult patients with acute promyelocytic leukemia (a single-center …
AAUS Hassan, AMJ Almothaffar - Iraqi Journal of Hematology, 2024 - journals.lww.com
BACKGROUND: Arsenic trioxide (ATO) regimen is now the standard of care for acute
promyelocytic leukemia (APL). The complete remission and possible cure are reported to be …
promyelocytic leukemia (APL). The complete remission and possible cure are reported to be …
[HTML][HTML] Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia: An Experience From a Resource-Constraint Country
W Thakur, N Anwar, N Fatima, A Jamal, QA Rizvi… - Cureus, 2022 - ncbi.nlm.nih.gov
Results A total of 85 APML patients were registered at our institute. Among them, 62 (73%)
were included in the analysis as per the inclusion criteria of the study. The median age was …
were included in the analysis as per the inclusion criteria of the study. The median age was …
[PDF][PDF] Overview of Iraqi experience in management of acute promyelocytic leukemia
W Al-Tameemi, ZS Shakir - The Medical Journal of Basrah University, 2021 - iasj.net
Abstract Objectives: In Iraq, leukemia is the 4th most common cancer, and acute
promyelocytic leukemia contributes to 2.83% and 3.18% of leukemia in Iraqi males and …
promyelocytic leukemia contributes to 2.83% and 3.18% of leukemia in Iraqi males and …